Expert Outlook: BeiGene Through The Eyes Of 4 Analysts
Portfolio Pulse from Benzinga Insights
BeiGene (NASDAQ:BGNE) has received mixed analyst ratings, with a recent average price target of $252.75, up from $221.00. Analysts from JP Morgan, JMP Securities, and Citigroup have raised their ratings and price targets, reflecting positive sentiment. BeiGene's revenue growth and net margin are strong, but its ROE and ROA are below industry averages.
October 22, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BeiGene has received a mix of bullish and somewhat bullish ratings from analysts, with a new average price target of $252.75, indicating positive sentiment. The company's revenue growth is strong, but it faces challenges with ROE and ROA.
The increase in the average price target from $221.00 to $252.75 and the positive ratings from analysts suggest a bullish outlook. The company's strong revenue growth supports this sentiment, although challenges in ROE and ROA may temper expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100